Sodium taurolithocholate

CAS No. 6042-32-6

Sodium taurolithocholate ( —— )

Catalog No. M19644 CAS No. 6042-32-6

The major human metabolite a bile acid which inhibits radioligand binding to muscarinic M1 but not to M2 or M3 receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 42 In Stock
25MG 66 In Stock
50MG 87 In Stock
100MG 132 In Stock
200MG 196 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium taurolithocholate
  • Note
    Research use only not for human use.
  • Brief Description
    The major human metabolite a bile acid which inhibits radioligand binding to muscarinic M1 but not to M2 or M3 receptors.
  • Description
    The major human metabolite a bile acid which inhibits radioligand binding to muscarinic M1 but not to M2 or M3 receptors.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6042-32-6
  • Formula Weight
    505.69
  • Molecular Formula
    C26H44NNaO5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 20 mg/mL
  • SMILES
    [Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ha C E Petersen C E Park D S et al. Investigations of the effects of ethanol on warfarin binding to human serum albumin[J]. 2000 7(2):114-121.
molnova catalog
related products
  • 1,1'-Methylenedi-2-n...

    1,1'-Methylenedi-2-naphthol target CYP2C19 - cytochrome P450 family 2 subfamily C member 19 (human).

  • 4,12-Dimethoxy-6-(7,...

    4,12-Dimethoxy-6-(7,8-dihydroxy-7,8-dihydrostyryl)-2-pyrone is a microbial metabolism of yangonin, a major styryl lactone from Piper methysticum.

  • Rilematovir

    JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.